Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
A Dose Finding Study of the Safety of Gemtuzumab Ozogamicin Combined With Conventional Chemotherapy for Patients With Relapsed or Refractory Acute Myeloid Leukemia
3 other identifiers
interventional
47
3 countries
76
Brief Summary
RATIONALE: Drugs used in chemotherapy work in different ways to stop cancer cells from dividing so they stop growing or die. Monoclonal antibodies such as gemtuzumab ozogamicin can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells. Combining monoclonal antibody therapy with combination chemotherapy may kill more cancer cells. PURPOSE: Phase I trial to study the effectiveness of combining gemtuzumab ozogamicin with combination chemotherapy in treating children who have relapsed or refractory acute myeloid leukemia or myelodysplastic syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1 leukemia
Started Jul 2002
Longer than P75 for phase_1 leukemia
76 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 4, 2002
CompletedStudy Start
First participant enrolled
July 1, 2002
CompletedFirst Posted
Study publicly available on registry
January 27, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2012
CompletedFebruary 20, 2014
February 1, 2014
4.2 years
January 4, 2002
February 18, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Event Free Survival
Length of study
Secondary Outcomes (3)
Toxicity
Remission Rate
Length of study
Prognostic Factor Analysis
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- Children's Oncology Grouplead
- National Cancer Institute (NCI)collaborator
Study Sites (76)
Comprehensive Cancer Center at University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
Phoenix Children's Hospital
Phoenix, Arizona, 85016-7710, United States
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205, United States
Jonathan Jaques Children's Cancer Center at Miller Children's Hospital
Long Beach, California, 90801, United States
Children's Hospital Los Angeles
Los Angeles, California, 90027, United States
Children's Hospital of Orange County
Orange, California, 92868, United States
Children's Hospital and Health Center - San Diego
San Diego, California, 92123-4282, United States
Stanford Cancer Center at Stanford University Medical Center
Stanford, California, 94305, United States
Children's Hospital Cancer Center
Denver, Colorado, 80218-1088, United States
Children's National Medical Center
Washington D.C., District of Columbia, 20010-2970, United States
University of Florida Shands Cancer Center
Gainesville, Florida, 32610-0232, United States
Florida Hospital Cancer Institute at Florida Hospital Orlando
Orlando, Florida, 32803-1273, United States
All Children's Hospital
St. Petersburg, Florida, 33701, United States
St. Joseph's Cancer Institute at St. Joseph's Hospital
Tampa, Florida, 33607, United States
Kaplan Cancer Center at St. Mary's Medical Center
West Palm Beach, Florida, 33407, United States
Emory University Hospital - Atlanta
Atlanta, Georgia, 30322, United States
Cancer Research Center of Hawaii
Honolulu, Hawaii, 95813, United States
Children's Memorial Hospital - Chicago
Chicago, Illinois, 60614, United States
Indiana University Cancer Center
Indianapolis, Indiana, 46202-5289, United States
St. Vincent Indianapolis Hospital
Indianapolis, Indiana, 46260, United States
Markey Cancer Center at University of Kentucky Chandler Medical Center
Lexington, Kentucky, 40536-0084, United States
CancerCare of Maine at Eastern Maine Medial Center
Bangor, Maine, 04401, United States
Alvin and Lois Lapidus Cancer Institute at Sinai Hospital
Baltimore, Maryland, 21215, United States
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, 21231-2410, United States
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
Boston, Massachusetts, 02115, United States
C.S. Mott Children's Hospital at University of Michigan
Ann Arbor, Michigan, 48109-0238, United States
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, 48201-1379, United States
Van Elslander Cancer Center at St. John Hospital and Medical Center
Grosse Pointe Woods, Michigan, 48236, United States
Children's Hospital of Minnesota - Minneapolis
Minneapolis, Minnesota, 55404, United States
Fairview University Medical Center - University Campus
Minneapolis, Minnesota, 55455, United States
Mayo Clinic Cancer Center
Rochester, Minnesota, 55905, United States
University of Mississippi Medical Center
Jackson, Mississippi, 39216-4505, United States
Children's Mercy Hospital
Kansas City, Missouri, 64108, United States
Siteman Cancer Center at Barnes-Jewish Hospital
St Louis, Missouri, 63110, United States
Cancer Center at Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
New Brunswick, New Jersey, 08903, United States
Newark Beth Israel Medical Center
Newark, New Jersey, 07112, United States
Herbert Irving Comprehensive Cancer Center at Columbia University
New York, New York, 10032, United States
James P. Wilmot Cancer Center at University of Rochester Medical Center
Rochester, New York, 14642, United States
SUNY Upstate Medical University Hospital
Syracuse, New York, 13210, United States
Blumenthal Cancer Center at Carolinas Medical Center
Charlotte, North Carolina, 28232-2861, United States
Duke Comprehensive Cancer Center
Durham, North Carolina, 27710, United States
Children's Hospital Medical Center of Akron
Akron, Ohio, 44308-1062, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229-3039, United States
Rainbow Babies and Children's Hospital
Cleveland, Ohio, 44106-5000, United States
Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, 44195-5217, United States
Columbus Children's Hospital
Columbus, Ohio, 43205-2696, United States
Children's Medical Center - Dayton
Dayton, Ohio, 45404-1815, United States
Tod Children's Hospital - Forum Health
Youngstown, Ohio, 44501, United States
Oklahoma University Medical Center
Oklahoma City, Oklahoma, 73104, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104-9786, United States
Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
Hollings Cancer Center at Medical University of South Carolina
Charleston, South Carolina, 29425, United States
Greenville Hospital System Cancer Center
Greenville, South Carolina, 29605, United States
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37232-6310, United States
Texas Tech University Health Sciences Center School of Medicine
Amarillo, Texas, 79106, United States
Children's Hospital of Austin
Austin, Texas, 78701, United States
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
Dallas, Texas, 75390, United States
Cook Children's Medical Center - Fort Worth
Fort Worth, Texas, 76104-9958, United States
M.D. Anderson Cancer Center at University of Texas
Houston, Texas, 77030-4009, United States
Methodist Children's Hospital of South Texas
San Antonio, Texas, 78229-3993, United States
University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78284-7811, United States
Massey Cancer Center at Virginia Commonwealth University
Richmond, Virginia, 23298-0037, United States
Children's Hospital and Regional Medical Center - Seattle
Seattle, Washington, 98105, United States
Providence Cancer Center at Sacred Heart Medical Center
Spokane, Washington, 99220-2555, United States
Edwards Comprehensive Cancer Center at Cabell Huntington Hospital
Huntington, West Virginia, 25701, United States
University of Wisconsin Comprehensive Cancer Center
Madison, Wisconsin, 53792-6164, United States
Marshfield Clinic - Marshfield Center
Marshfield, Wisconsin, 54449, United States
Midwest Children's Cancer Center
Milwaukee, Wisconsin, 53226, United States
Princess Margaret Hospital for Children
Perth, Western Australia, 6001, Australia
McMaster Children's Hospital at Hamilton Health Sciences
Hamilton, Ontario, L8N 3Z5, Canada
Children's Hospital of Eastern Ontario
Ottawa, Ontario, K1H 8L1, Canada
McGill Cancer Centre at McGill University
Montreal, Quebec, H3H 1P3, Canada
Hopital Sainte Justine
Montreal, Quebec, H3T 1C5, Canada
Centre Hospitalier Universitaire de Quebec
Ste-Foy, Quebec, G1V 4G2, Canada
Related Publications (1)
Aplenc R, Alonzo TA, Gerbing RB, Lange BJ, Hurwitz CA, Wells RJ, Bernstein I, Buckley P, Krimmel K, Smith FO, Sievers EL, Arceci RJ; Children's Oncology Group. Safety and efficacy of gemtuzumab ozogamicin in combination with chemotherapy for pediatric acute myeloid leukemia: a report from the Children's Oncology Group. J Clin Oncol. 2008 May 10;26(14):2390-3295. doi: 10.1200/JCO.2007.13.0096.
PMID: 18467731RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Richard Aplenc, MD, MSCE
Children's Hospital of Philadelphia
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Purpose
- TREATMENT
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 4, 2002
First Posted
January 27, 2003
Study Start
July 1, 2002
Primary Completion
September 1, 2006
Study Completion
March 1, 2012
Last Updated
February 20, 2014
Record last verified: 2014-02